NCT06586775

Brief Summary

Endodontic research on the effects of DM on pulp tissues is scarce. Diabetic human and animal histological research demonstrated a decreased reparatory response in the pulp, resulting in chronic pulp inflammation and reduced dentin bridge formation. To date, there is no human clinical trial examining the impact of diabetes mellitus on teeth with irreversible pulpitis. As a result of the paucity of data in the literature, there is a clinical dilemma whether to recommend vital pulp therapy techniques or root canal treatment in diabetic patients with irreversible pulpitis. To the best of our knowledge, no prospective study has evaluated the outcome of complete pulpotomy in T2DM patients and healthy controls with irreversible pulpitis. The aim of this preliminary study is to compare and evaluate the success rates of pulpotomy in healthy and type 2 diabetes mellitus patients in mature permanent teeth presenting with clinical symptoms of irreversible pulpitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 6, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
Last Updated

September 19, 2024

Status Verified

November 1, 2023

Enrollment Period

1 year

First QC Date

December 6, 2023

Last Update Submit

September 4, 2024

Conditions

Keywords

Pulpotomyirreversible pulpitisType 2 Diabetes

Outcome Measures

Primary Outcomes (1)

  • Treatment outcome

    Outcome of complete pulpotomy in healthy and diabetic patients through clinical and radiographic findings.

    6 and 12 month follow-up.

Secondary Outcomes (1)

  • 1) Effect of treatment on glycated haemoglobin levels in diabetic patients

    3 months post-treatment

Study Arms (2)

diabetic group

EXPERIMENTAL

complete pulpotomy will be performed in teeth with irreversible pulpitis in diabetic patients.

Procedure: Pulpotomy

Healthy group

ACTIVE COMPARATOR

complete pulpotomy will be performed in teeth with irreversible pulpitis in systemically healthy patients.

Procedure: Pulpotomy

Interventions

PulpotomyPROCEDURE

complete pulpotomy

Healthy groupdiabetic group

Eligibility Criteria

Age18 Years - 70 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsGender matched healthy control participants to the same gender diabetic individuals will be analyzed.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 2 diabetes mellitus with HbA1c \> 6.5% with no other co-morbidities.
  • Age and gender matched healthy patients
  • Age between 18 - 70 years.
  • Mature permanent teeth with clinical and radiographic signs and symptoms indicative of irreversible pulpitis (PAI score ≤2)
  • Tooth showing positive response to pulp sensibility testing.

You may not qualify if:

  • Patients with immunocompromised diseases or systematic diseases (other than diabetes mellitus)
  • Smokers, pregnant and lactating women
  • Teeth with immature roots or retained deciduous tooth.
  • Bleeding could not be controlled in ≥8 minutes.
  • Tooth with signs and symptoms of apical periodontitis.
  • Tooth with probing depth more than 4mm.
  • Positive history of antibiotic use in the past 1 month or requiring antibiotic prophylaxis and/or analgesic usage in past 3 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr.keerthana

Rohtak, Haryana, 124001, India

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Pulpotomy

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

EndodonticsDentistry

Study Officials

  • Dr.keerthana G, MDS

    PGIDS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The investigator and the outcome assessor will be blinded with the participants preoperative characteristics and allocation group.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2023

First Posted

September 19, 2024

Study Start

August 1, 2023

Primary Completion

July 31, 2024

Study Completion

August 1, 2024

Last Updated

September 19, 2024

Record last verified: 2023-11

Locations